Ultrasound measurements of ventricular wall motion following administration of vasoactive drugs.
D000328:Adult; D001022:Aortic Valve Insufficiency / Q000503:physiopathology; D001285:Atropine / Q000494:pharmacology*; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D006328:Cardiac Catheterization; D002302:Cardiac Output / Q000187:drug effects; D002312:Cardiomyopathy, Hypertrophic / Q000503:physiopathology; D004452:Echocardiography; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects*; D006801:Humans; D006919:Hydroxyzine / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology*; D008297:Male; D008729:Methoxamine / Q000494:pharmacology*; D008875:Middle Aged; D008946:Mitral Valve Stenosis / Q000503:physiopathology; D009119:Muscle Contraction / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology; D014463:Ultrasonography; D016276:Ventricular Function
D006919:Hydroxyzine; D001285:Atropine; D011433:Propranolol; D008729:Methoxamine; D007545:Isoproterenol